CytoSwim

PATH FERTILITY

This company develops epigenetic sperm quality tests for men and clinicians to identify subfertility missed by standard semen analysis.

Imvitro

Imvitro develops an artificial intelligence platform for embryo selection to help fertility clinics improve success rates and transparency for IVF patients.

Paterna Biosciences

Paterna Biosciences develops in vitro spermatogenesis technology to produce functional sperm from stem cells for clinics treating male infertility.

illumicell

Illumicell AI develops a portable cellular imaging platform for rapid, point-of-care semen analysis serving fertility clinics, urologists and pharmaceutical companies.

FertereX

This company develops a photobiomodulation therapy device designed to improve sperm quality and testosterone levels for men experiencing fertility issues.

Genomic Prediction

The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.

Future Fertility

This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.

Béa Fertility

This company manufactures at-home intracervical insemination kits for individuals and couples seeking affordable fertility treatment without clinic-based procedures.